Cargando…

Beta-blockers and Short-Term Cardiovascular Outcomes In Patients Hospitalized For Acute Coronary Syndrome and a Left Ventricular Ejection Fraction ≥40%

Beta-blockers (BB) have been traditionally associated with improvement in cardiovascular disease outcomes in patients with ischemic cardiomyopathy. Whether they’re still efficacious in the post-reperfusion era is currently debated in the light of recent controversial reports. In-hospital, 6-month an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abi Khalil, Charbel, Zubaid, Mohammad, Mekhaimar, Menatalla, Asaad, Nidal, Mahfoud, Ziyad, Al Suwaidi, Jassim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044295/ https://www.ncbi.nlm.nih.gov/pubmed/32103115 http://dx.doi.org/10.1038/s41598-020-60528-y

Ejemplares similares

Non-withdrawal of beta blockers in acute decompensated chronic and de novo heart failure with reduced ejection fraction in a prospective multicentre study of patients with acute heart failure in the Middle East
por: Abi Khalil, Charbel, et al.
Publicado: (2017)

Diabetes-related cardiovascular and economic burden in patients hospitalized for heart failure in the US: a recent temporal trend analysis from the National Inpatient Sample
por: Mekhaimar, Menatalla, et al.
Publicado: (2020)

Diabetes outcomes in heart failure patients with hypertrophic cardiomyopathy
por: Mekhaimar, Menatalla, et al.
Publicado: (2022)

Hypoglycemia is associated with a higher risk of mortality and arrhythmias in ST-elevation myocardial infarction, irrespective of diabetes
por: Humos, Basel, et al.
Publicado: (2022)

β‐Blocker Therapy Prior to Admission for Acute Coronary Syndrome in Patients Without Heart Failure or Left Ventricular Dysfunction Improves In‐Hospital and 12‐Month Outcome: Results From the GULF‐RACE 2 (Gulf Registry of Acute Coronary Events‐2)
por: Abi Khalil, Charbel, et al.
Publicado: (2017)

Red Cell Distribution Width Is Associated with All-Cause and Cardiovascular Mortality in Patients with Diabetes
por: Al-Kindi, Sadeer G., et al.
Publicado: (2017)

Aggressive beta-blocker titration in stabilized acute heart failure patients with low left ventricular ejection fraction
por: Waranugraha, Yoga, et al.
Publicado: (2021)

Incidence and impact of cardiorenal anaemia syndrome on all‐cause mortality in acute heart failure patients stratified by left ventricular ejection fraction in the Middle East
por: Al‐Jarallah, Mohammed, et al.
Publicado: (2018)

Cardiac Complications of Diabetes
por: Abi Khalil, Charbel, et al.
Publicado: (2018)

Left ventricular contractile performance and heart failure in patients with left ventricular ejection fraction more than 40%
por: Kitada, Shuichi, et al.
Publicado: (2020)

Aspirin Use and Cardiovascular Outcome in Patients With Type 2 Diabetes Mellitus and Heart Failure: A Population‐Based Cohort Study
por: Abi Khalil, Charbel, et al.
Publicado: (2018)

Effects of Beta-Blockers on Heart Failure with Preserved Ejection Fraction: A Meta-Analysis
por: Liu, Feng, et al.
Publicado: (2014)

Effect of Race on Left Ventricular Ejection Fraction Decline After Initial Improvement with Beta Blockers in Patients with Non-Ischemic Cardiomyopathy: A Retrospective Analysis
por: Kelesidis, Iosif, et al.
Publicado: (2013)

Temporal Trends in Outcomes of ST-Elevation Myocardial Infarction Patients With Heart Failure and Diabetes
por: Ali, Bassem, et al.
Publicado: (2022)

Trends and Outcomes of Aortic Valve Replacement in Patients With Diabetes in the US
por: Khan, Sarah, et al.
Publicado: (2022)

Impact of diabetes on mortality and rehospitalization in acute heart failure patients stratified by ejection fraction
por: Al‐Jarallah, Mohammed, et al.
Publicado: (2019)

Circulating troponin and further left ventricular ejection fraction improvement in patients with previously recovered left ventricular ejection fraction
por: Howlett, Jonathan G., et al.
Publicado: (2020)

Prognostic impacts of changes in left ventricular ejection fraction in heart failure patients with preserved left ventricular ejection fraction
por: Yoshihisa, Akiomi, et al.
Publicado: (2020)

Beta-blocker use and cardiovascular event risk in patients with heart failure with preserved ejection fraction
por: Tsujimoto, Tetsuro, et al.
Publicado: (2018)

Resting heart rate in ambulatory heart failure with reduced ejection fraction treated with beta‐blockers
por: Varian, Kenneth D., et al.
Publicado: (2020)

The progress and controversial of the use of beta blockers in patients with heart failure with a preserved ejection fraction
por: Xu, Xizhen, et al.
Publicado: (2019)

Heart Failure With Midrange Ejection Fraction: Prior Left Ventricular Ejection Fraction and Prognosis
por: Zhang, Xinxin, et al.
Publicado: (2021)

Macrovascular Complications in Patients with Diabetes and Prediabetes
por: Huang, Dou, et al.
Publicado: (2017)

Primary hyperaldosteronism is associated with increased mortality and morbidity in patients with hypertension and diabetes
por: Pillai, Krishnadev, et al.
Publicado: (2023)

Type 2 diabetes and in-hospital sudden cardiac arrest in ST-elevation myocardial infarction in the US
por: Mhaimeed, Omar, et al.
Publicado: (2023)

Clinical tolerability of generic versus brand beta blockers in heart failure with reduced left ventricular ejection fraction: a retrospective cohort from heart failure clinic
por: Chanchai, Rattanachai, et al.
Publicado: (2018)

Differing effects of beta-blockers on long-term clinical outcomes following percutaneous coronary intervention between patients with mid-range and reduced left ventricular ejection fraction
por: Shitara, Jun, et al.
Publicado: (2021)

Acute myocarditis and pulmonary edema due to scorpion sting
por: Ismail, Montaser, et al.
Publicado: (2016)

Myocardial strain to identify benefit from beta‐blockers in patients with heart failure with reduced ejection fraction
por: Park, Chan Soon, et al.
Publicado: (2022)

Mortality and socio-economic outcomes among patients hospitalized for stroke and diabetes in the US: a recent analysis from the National Inpatient Sample
por: Tabbalat, Aya, et al.
Publicado: (2021)

Association of the medical therapy with beta-blockers or inhibitors of renin-angiotensin system with clinical outcomes in patients with mildly reduced left ventricular ejection fraction after acute myocardial infarction
por: Joo, Seung-Jae, et al.
Publicado: (2022)

How to standardize the measurement of left ventricular ejection fraction
por: Kusunose, Kenya, et al.
Publicado: (2021)

The effect of idiopathic premature ventricular complexes on left ventricular ejection fraction
por: Altıntaş, Bernas, et al.
Publicado: (2019)

The Use of β-Blockers in Heart Failure with Reduced Ejection Fraction
por: Masarone, Daniele, et al.
Publicado: (2021)

Effect of the angiotensin-receptor-neprilysin inhibitor in heart failure patients with left ventricular ejection fraction higher than 40%
por: Zhao, Mingyue, et al.
Publicado: (2019)

Revisiting the relationship between left ventricular ejection fraction and ventricular–arterial coupling
por: Mihaileanu, Serban, et al.
Publicado: (2020)

Hyperdynamic left ventricular ejection fraction in the intensive care unit
por: Paonessa, Joseph R., et al.
Publicado: (2015)

Left Ventricular Ejection Fraction and Volumes: It Depends on the Imaging Method
por: Wood, Peter W, et al.
Publicado: (2014)

Impact of left ventricular ejection fraction on the results of cardiac rehabilitation
por: Peters, R. J. G.
Publicado: (2019)

Beta-Blockers in Heart Failure with Preserved Ejection Fraction: Could Their Use Be Vindicated as an Acceptable Option in the Future Treatment Guideline?
por: Cho, Jae Yeong
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ve5e5ub9nkjerb2l8piqpsv9s1